[{"status": "Ongoing", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA211817"], "brand_name": ["TESTOSTERONE CYPIONATE"], "generic_name": ["TESTOSTERONE CYPIONATE"], "manufacturer_name": ["Eugia US LLC"], "product_ndc": ["55150-276", "55150-277", "55150-278"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR"], "substance_name": ["TESTOSTERONE CYPIONATE"], "rxcui": ["835829", "835840", "2047882"], "spl_id": ["b622f795-00fa-48e3-8e4d-679c2ce28c6c"], "spl_set_id": ["f901e2b2-f143-4237-8e95-0d134585490b"], "package_ndc": ["55150-276-01", "55150-277-01", "55150-278-01"], "is_original_packager": [true], "upc": ["0355150276011", "0355150278015", "0355150277018"], "unii": ["M0XW1UBI14"]}, "product_type": "Drugs", "event_id": "96680", "recalling_firm": "Eugia US LLC", "address_1": "279 Princeton Hightstown Rd", "address_2": "", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0363-2025", "product_description": "Testosterone Cypionate Injection, USP, CIII, 200mg per mL, Rx only, 1mL Single-Dose Vial,  Distributed by Eugia US LLC, E. Windsor, NJ, Manufactured by: Eugia Specialties Limited, Telangana State, India, NDC 55150-277-01", "product_quantity": "36,816 vials", "reason_for_recall": "cGMP: complaints of crystals not redissolving into solution after warming and shaking the vials.", "recall_initiation_date": "20250410", "center_classification_date": "20250414", "report_date": "20250423", "code_info": "Lot #: 1TC24075A, Exp 11/30/2026.", "more_code_info": ""}, {"status": "Ongoing", "city": "Nicholasville", "state": "KY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89909", "recalling_firm": "TMC Acquisition LLC dba Tailor Made Compounding", "address_1": "200 Moore Dr", "address_2": "", "postal_code": "40356-8512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and Puerto Rico", "recall_number": "D-1207-2022", "product_description": "Gonadorelin 100mcg/mL, 10mL per vial, Refrigerate, Tailor Made Compounding", "product_quantity": "294 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20220307", "center_classification_date": "20220714", "report_date": "20220720", "code_info": "Batch #: 01062225B, Exp 4/6/2022; 01142207A1, Exp 4/14/2022; 02012228A1, Exp 5/2/2022; 02032203A1, Exp 5/4/2022; 03012211A1, Exp 5/30/2022; 03082240A1, Exp 6/6/2022.", "more_code_info": ""}, {"status": "Terminated", "city": "Hauppauge", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "90551", "recalling_firm": "Loud Muscle Science", "address_1": "300 Oser Ave", "address_2": "N/A", "postal_code": "11788-3608", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "The product was distributed nationwide in the USA and Canada.", "recall_number": "D-1338-2022", "product_description": "Launch Sequence Aphrodisia Capsules, 4-count tins, ASIN B07QB3S2LV, UPC Code 661020846957.", "product_quantity": "500 4-count tins", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: Product found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.", "recall_initiation_date": "20220627", "center_classification_date": "20220815", "termination_date": "20230208", "report_date": "20220727", "code_info": "Lot # 2022104, exp. date 04/2025"}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72594", "recalling_firm": "Walgreens Infusion Services", "address_1": "14220 Northbrook Dr Ste 100B", "address_2": "N/A", "postal_code": "78232-5045", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Texas", "recall_number": "D-0529-2016", "product_description": "Piperacillin/Tazobactam (Zosyn)  Accuflo bag, a) 18 g/NS 275 mL  b) 4.5 g/NS 100 mL Accuflo, Rx Only, Compounded by Option Care 148, San Antonio, TX 78232-5045", "product_quantity": "26 Accuflo bags", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20151110", "center_classification_date": "20151230", "termination_date": "20171018", "report_date": "20160106", "code_info": "All lots within expiry."}, {"status": "Terminated", "city": "Yuyao", "state": "N/A", "country": "China", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "83018", "recalling_firm": "NingBo Huize Commodity Co.,Ltd.", "address_1": "14 Lizhou Road", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Foreign manufacturer located in China and distributed to seven consignees located in China.", "recall_number": "D-1541-2019", "product_description": "DOTS SCENTED ANTIBACTERIAL HAND GEL LEMON (Ethyl Alcohol 62%), 1.35 fl oz / 40 mL, OTC, Distributed by: JFL Enterprises, Inc. Cleveland, Ohio 44102.", "product_quantity": "3852", "reason_for_recall": "CGMP deviations: Stability testing was not conducted on manufactured sunscreen and hand sanitizer OTC products.", "recall_initiation_date": "20190401", "center_classification_date": "20190727", "termination_date": "20230606", "report_date": "20190807", "code_info": "Lot #: 20181024, Exp 10/23/2020"}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-062-2014", "product_description": "Betamethasone 10mg 10ml, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "10 units", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"country": "United States", "city": "Little Rock", "address_1": "1527 S Bowman Rd Ste D", "reason_for_recall": "Lack of Assurance of Sterility: Sterility of product is not assured.", "address_2": "", "product_quantity": "2 Syringes", "code_info": "Compounded on 05/27/15, Discard After: 06/10/15", "center_classification_date": "20150701", "distribution_pattern": "United States including: Arkansas", "state": "AR", "product_description": "Diphenhydramine HCl, Diphenhydramine 25mg / NS 10 ml syringe, Qty: 2 10 mL syringes, Rx Only.  Compounded by: United Medical IV Center (Little Rock) 1527 South Bowman Rd. Ste. D Little Rock, AR 72211-4200.", "report_date": "20150708", "classification": "Class II", "openfda": {}, "recalling_firm": "Lincare, Inc.", "recall_number": "D-1190-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71415", "termination_date": "20170216", "more_code_info": "", "recall_initiation_date": "20150528", "postal_code": "72211-4200", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Skillman", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88288", "recalling_firm": "Johnson & Johnson Consumer, Inc.", "address_1": "199 Grandview Rd", "address_2": "N/A", "postal_code": "08558-1311", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide in US", "recall_number": "D-0838-2021", "product_description": "Neutrogena Ultra Sheer body mist sunscreen BROAD SPECTRUM SPF 70,  Avobenzone (3%), Homosalate (15%), Octisalate (5%), Octocrylene (10%), NET WT. 5.0 OZ (141 g) aerosol can, Distributed by: JOHNSON & JOHNSON CONSUMER, INC. Skillman, NJ 08858, UPC 0 86800 10040 9", "product_quantity": "2,724,480 cans", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20210714", "center_classification_date": "20210924", "report_date": "20211006", "code_info": "All lots within expiry."}, {"status": "Terminated", "city": "Cincinnati", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89106", "recalling_firm": "The Procter & Gamble Company", "address_1": "1 Procter And Gamble Plz", "address_2": "N/A", "postal_code": "45202-3315", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA and Puerto Rico, Canada, Guam, Northern Mariana Islands, American Samoa, Bhutan, Timor-Leste, Maldives, Fiji, US Virgin Islands, Trinidad, Peru, Saint Marteen, Bahamas, Costa Rica, Guatemala, Honduras, Panama, Belize, Santa Lucia, Aruba, Dominican Republic, Guyana", "recall_number": "D-0251-2024", "product_description": "Old Spice, SWEAT DEFENSE PURE SPORT PLUS, (Aluminum Chlorohydrate 23.5%), Anti-Perspirant, Topical spray can, Net WT 3.8 oz (107 g) cans,  Distr. by: Procter & Gamble, Cincinnati, OH 45202. NDC: 69423-387-10, UPC 0 37000 72974 7", "product_quantity": "unknown", "reason_for_recall": "CGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzene", "recall_initiation_date": "20211123", "center_classification_date": "20240117", "termination_date": "20241001", "report_date": "20240124", "code_info": "All lots with expiry through September 2023"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-734-2015", "product_description": "Irbesartan active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "50 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-296-2014", "product_description": "Testosterone Pellet 112mg, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "5 units", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "distributed prior to and including 05/23/2013"}, {"status": "Terminated", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72746", "recalling_firm": "Sentara Enterprises", "address_1": "535 Independence Pkwy Ste 300", "address_2": "N/A", "postal_code": "23320-5176", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "U.S. Including: VA, NC", "recall_number": "D-0616-2016", "product_description": "Milrinone in 0.45% NS, Packaged as a) 52MG in 65ML Homepumps, b) 80MG in 100ML Homepumps, c) 92MG in 115ML Homepumps, d) 104MG in 130ML Homepumps, e) 112MG in 140ML Homepumps, f) 120MG in 150ML Homepumps, g) 124MG in 155ML Homepumps, h) 128MG in 160ML, i) 136MG in 170ML Homepumps, j) 144MG in 180ML Homepumps, k) 152MG in 190ML Homepumps, l) 160MG in 200ML Homepumps, m) 172MG in 215ML Homepumps, n) 176MG in 220ML Homepumps, and o) 200MG in 250ML Homepumps, Rx Only. SENTARA HOME HEALTH SENTARA RX, 535 Independence Pkwy ste.300, Chesapeake, VA 23320-5176.", "product_quantity": "a) 7, b) 4, c) 8, d) 8, e) 3, f) 4, g) 4, h) 3, i) 4, j) 4, k) 3, l) 3, m) 9, n) 6, o) 3 Bags", "reason_for_recall": "Lack of Assurance of Sterility: Product sterility cannot be guaranteed.", "recall_initiation_date": "20150918", "center_classification_date": "20160128", "termination_date": "20160629", "report_date": "20160203", "code_info": "All Lots compounded between 11-Sep-15 and 17-Sep-15. Expiries: a) 1-Oct-15, b) 29-Sep-15, c) 25-Sep-15, 30-Sep-15, d) 25-Sep-15, e) 1-Oct-15, f) 29-Sep-15, g) 26-Sep-15, h) 1-Oct-15, i) 29-Sep-15, j) 25-Sep-15, k) 1-Oct-15, l) 25-Sep-15, m) 27-Sep-15, 1-Oct-15, n) 24-Sep-15, 30-Sep-15, o) 25-Sep-15"}, {"status": "Ongoing", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA074802"], "brand_name": ["KETOROLAC TROMETHAMINE"], "generic_name": ["KETOROLAC TROMETHAMINE"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-3793", "0409-3795", "0409-3796"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["KETOROLAC TROMETHAMINE"], "rxcui": ["860092", "1665459", "1665461"], "spl_id": ["60f4ed51-f1c1-45d4-b43a-969678901bdd"], "spl_set_id": ["8accbb78-fc64-45d5-69b0-35c23a1d2a2e"], "package_ndc": ["0409-3793-19", "0409-3793-01", "0409-3793-25", "0409-3795-19", "0409-3795-01", "0409-3795-25", "0409-3796-19", "0409-3796-01", "0409-3796-25", "0409-3796-49"], "is_original_packager": [true], "unii": ["4EVE5946BQ"]}, "product_type": "Drugs", "event_id": "71681", "recalling_firm": "Hospira Inc.", "address_1": "600 N Field Dr", "address_2": "N/A", "postal_code": "60045-4835", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide, Puerto Rico, Guam, Canada and Singapore", "recall_number": "D-1242-2015", "product_description": "KETOROLAC Tromethamine Inj., USP, 60 mg (30 mg/mL), 2 mL Fill Single-dose Vials, I.V/I.M. USE, Hospira, Inc., Lake Forest, IL 60045 --- NDC 0409-3796-01 ---- ALSO labeled under NOVAPLUS label NDC 0409-3796-49", "product_quantity": "5,214,900 vials (Hospira label); 250,600 vials (NOVAPLUS label)", "reason_for_recall": "Crystallization; identified as calcium salt of Ketorolac", "recall_initiation_date": "20150630", "center_classification_date": "20150715", "report_date": "20150722", "code_info": "31075DK, 31076DK, EXP01JUL2015; 32345DK, 32368DK, EXP 01AUG2015; 33152DK, EXP 01SEP2015; 34538DK, EXP 01OCT2015; 37227DK, EXP 01JAN2016, 41525DK, 42255DK, EXP 01MAY2016; 46042DK, 46045DK, 46048DK, 46304DK, 46305DK, 46432DK, 46433DK, EXP 01OCT2016 AND NOVAPLUS LOT 31074DK, EXP 01JUL2015", "more_code_info": ""}, {"status": "Terminated", "city": "Brookhaven", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA040765"], "brand_name": ["EXTENDED PHENYTOIN SODIUM"], "generic_name": ["PHENYTOIN SODIUM"], "manufacturer_name": ["Amneal Pharmaceuticals LLC"], "product_ndc": ["65162-212"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PHENYTOIN SODIUM"], "rxcui": ["855671"], "spl_id": ["2b4f7d43-b5df-46e4-9cb9-216b70a360a0"], "spl_set_id": ["7e467c02-49a0-4b62-b537-430fdfa4f10e"], "package_ndc": ["65162-212-03", "65162-212-10", "65162-212-50", "65162-212-11"], "is_original_packager": [true], "upc": ["0365162212037", "0365162212105"], "unii": ["4182431BJH"]}, "product_type": "Drugs", "event_id": "93292", "recalling_firm": "Amneal Pharmaceuticals of New York, LLC", "address_1": "50 Horseblock Rd", "address_2": "", "postal_code": "11719-9509", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0090-2024", "product_description": "Extended Phenytoin Sodium Capsules, USP, 100 mg, 100-count bottle, Distributed by Amneal Pharmaceuticals LLC Bridgewater, NJ, 08807, NDC# 65162-212-10", "product_quantity": "9,263 100-count bottles", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20231027", "center_classification_date": "20231107", "termination_date": "20250806", "report_date": "20231115", "code_info": "Lot # HM03221A, Exp. date 12/31/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0937-2019", "product_description": "NET Remedies #6 (Orange Label) Homeopathic Preparation, Oral Liquid, 57 mL, Manufacturer: King Bio Inc. U.S.A., Supplier: NET (Australia) Pty LTD 428 Hume Street, Toowoomba QLD 4350, Australia", "product_quantity": "595 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: AUS-020118C Exp. 02/20; AUS-022418C Exp. 02/20; AUS-071718T Exp. 07/20; AUS-101117C Exp. 10/19"}, {"status": "Completed", "city": "Norwalk", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92857", "recalling_firm": "Ecometics, Inc.", "address_1": "19 Concord St", "address_2": "N/A", "postal_code": "06854-3706", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1101-2023", "product_description": "AstrinGyn (Ferric Subsulfate) Aqueous, 259 mg/g, 8 gm Single Use Vials, Manufactured for CooperSurgical, Trumbull, CT 06611, NDC 59365-6065-0, Ref 6065.", "product_quantity": "92,967 vials", "reason_for_recall": "CGMP Deviations: Products not manufactured under current good manufacturing practices.", "recall_initiation_date": "20230809", "center_classification_date": "20230824", "report_date": "20230830", "code_info": "Lot #: 2E144A, 2E157A, exp: 11/2023; 2E270A, exp: 3/2024; 2E300A, exp: 4/2024"}, {"status": "Completed", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91466", "recalling_firm": "Sentara Infusion Services", "address_1": "535 Independence Pkwy Ste 300", "address_2": "N/A", "postal_code": "23320-5176", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Dispensed to Patients Nationwide.", "recall_number": "D-0304-2023", "product_description": "METHADONE (a) 2.5MG IN 5ML NS SYRINGE, (b) 4MG IN 5ML NS SYRINGE, pain, Rx Only,  Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320", "product_quantity": "19 syringes", "reason_for_recall": "Lack of sterility assurance", "recall_initiation_date": "20221227", "center_classification_date": "20230215", "report_date": "20230222", "code_info": "Beyond Use Date: December 28-29, 2022"}, {"country": "United States", "city": "Springerville", "address_1": "105 W Main St", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "2 containers", "code_info": "all lots", "center_classification_date": "20151201", "distribution_pattern": "Nationwide in US: Arizona, California, Georgia, New Mexico, South Carolina, South Dakota, Texas, and Utah", "state": "AZ", "product_description": "Heparin 1000 Unit/mL Injection, Rx, Western Drug Inc. 106 E. Main Street, Springerville, Arizona 85938", "report_date": "20151209", "classification": "Class II", "openfda": {}, "recalling_firm": "Western Drug", "recall_number": "D-0429-2016", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "72520", "termination_date": "20161001", "more_code_info": "", "recall_initiation_date": "20151019", "postal_code": "85938-7203", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91788", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0812-2023", "product_description": "IC-Green (indocyanine green for injection, USP) 25 mg/10 mL Kit, Rx Only, Sterile, Manufactured by: Akorn, Inc., Lake Forest, IL 60045.  ALL NDCs", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Firm went out of business and could no longer continue stability studies.", "recall_initiation_date": "20230426", "center_classification_date": "20230601", "report_date": "20230607", "code_info": "All Lots"}, {"status": "Terminated", "city": "Waterford", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79149", "recalling_firm": "American Pharmaceutical Ingredients LLC", "address_1": "6650 Highland Rd Ste 302", "address_2": "N/A", "postal_code": "48327-1665", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within USA.", "recall_number": "D-0480-2018", "product_description": "Clonidine HCl USP for prescription compounding, packaged in a) 5g (NDC 58597-8010-2); b) 10g (NDC 58597-8010-3); c) 25g (NDC 58597-8010-4); d)100g (NDC 58597-8010-6), RX only, packed by American Pharmaceutical Ingredients, LLC 6650 Highland Road, Waterford, MI 48327", "product_quantity": "5000 g", "reason_for_recall": "CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.", "recall_initiation_date": "20180209", "center_classification_date": "20180222", "termination_date": "20191202", "report_date": "20180228", "code_info": "Lot #: a) 070915-1, Exp. 12/31/2019; b) 070915-1, Exp. 12/31/2019; c) 070915-1, Exp. 12/31/2019; d) 070915-1, Exp. 12/31/2019"}, {"status": "Ongoing", "city": "Navi Mumbai", "state": "", "country": "India", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "93357", "recalling_firm": "Kilitch Healthcare India Limited", "address_1": "R - 904 905 T T C Industrial Road", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0308-2024", "product_description": "Multi-action Relief Drops (Polyvinyl alcohol 0.5%, Providone 0.6%, Tetrahydrozoline Hydrochloride 0.05%), packaged in 0.5 FL OZ (15 mL) bottles, Distributed by: Rite Aid 30 Hunter Lane, Camp Hill, PA 17011, NDC 11822-2254-3", "product_quantity": "9,216 bottles", "reason_for_recall": "Non-Sterility", "recall_initiation_date": "20231113", "center_classification_date": "20240205", "report_date": "20240214", "code_info": "All lots", "more_code_info": ""}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78828", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0446-2018", "product_description": "Potassium Chloride in 5% Dextrose in all strengths, all doses, and all packaging.", "product_quantity": "Unknown", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20171227", "center_classification_date": "20180220", "termination_date": "20200507", "report_date": "20180228", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Shenandoah", "state": "IA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62511", "recalling_firm": "Lloyd Inc. of Iowa", "address_1": "604 W Thomas Ave", "address_2": "N/A", "postal_code": "51601-1744", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Distribution was nationwide, including Puerto Rico.  There was no foreign, military, or government distribution.", "recall_number": "D-081-2013", "product_description": "Levothroid (levothyroxine sodium tablets, USP),125 mcg., 100-count bottles, Rx only, NDC 0456-1324-01,   Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA.", "product_quantity": "19,162/100-tablet bottles", "reason_for_recall": "cGMP Deviations; does not meet in process specification requirements", "recall_initiation_date": "20120709", "center_classification_date": "20121203", "termination_date": "20131114", "report_date": "20121212", "code_info": "Lot #1095210, exp. 4/30/2013"}, {"country": "United States", "city": "North Wales", "address_1": "1090 Horsham Rd", "reason_for_recall": "Labeling: Not Elsewhere Classified: Lack of leaflets and approved labels on bottles.", "address_2": "", "product_quantity": "576 bottles", "code_info": "Lot #: 05N533, Exp 11/16", "center_classification_date": "20160311", "distribution_pattern": "Nationwide and Puerto Rico.", "state": "PA", "product_description": "NABUMETONE Tablets USP, 750 mg, 100 count bottle,Teva Pharmaceutical Industries Ltd., Jerusalem, 91010, ISRAEL", "report_date": "20160323", "classification": "Class III", "openfda": {}, "recalling_firm": "Teva Pharmaceuticals USA", "recall_number": "D-0773-2016", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "72999", "termination_date": "20161115", "more_code_info": "", "recall_initiation_date": "20151119", "postal_code": "19454-1505", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Athens", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83074", "recalling_firm": "RXQ Compounding LLC", "address_1": "340 W State St Unit 9", "address_2": "N/A", "postal_code": "45701-1564", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA", "recall_number": "D-1693-2019", "product_description": "PHO-TID-CHOL 50MG/ DEOXYCHOLIC 42 MG/ML INJ, 30 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0953-30", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190619", "center_classification_date": "20190808", "termination_date": "20220916", "report_date": "20190814", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Sugar Land", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77634", "recalling_firm": "PharMedium Services, Llc", "address_1": "12620 W Airport Blvd Ste 130", "address_2": "N/A", "postal_code": "77478-6200", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0986-2017", "product_description": "Potassium PHOSphate in 0.9% Sodium Chloride Injection, 10 mMol in a) 100 mL in 150 mL Intravia Bag (NDC 61553-288-48) Service Code: 2K5288, and b) 250 mL in 250 mL Intravia Bag (NDC 61553-281-11) Service Code: 2K5281, Rx Only, PharMEDium Services, LLC 12620 W. Airport Blvd #130 Sugar Land, TX 77478 800-523-7749", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility; media fill failure at manufacturer", "recall_initiation_date": "20170626", "center_classification_date": "20170714", "termination_date": "20200429", "report_date": "20170726", "code_info": "Lots: a) 171280006S Exp. 8/6/2017; 171280125S Exp. 8/7/2017; 171290006S Exp. 8/7/2017; 171290028D Exp. 8/8/2017; 171360002S Exp. 8/15/2017; b) 171280011S Exp. 8/7/2017"}, {"status": "Ongoing", "city": "Nicholasville", "state": "KY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89909", "recalling_firm": "TMC Acquisition LLC dba Tailor Made Compounding", "address_1": "200 Moore Dr", "address_2": "", "postal_code": "40356-8512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and Puerto Rico", "recall_number": "D-1231-2022", "product_description": "Testosterone Cypionate (GSO) 200mg/ml a) 2 mL-vial, b) 4 mL-vial, c) 5 mL-vial, d) 10 mL-vial, Room temperature, Tailor Made Compounding", "product_quantity": "4,219 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20220307", "center_classification_date": "20220714", "report_date": "20220720", "code_info": "Batch#: a)12212105A2, Exp 6/19/2022; 02182229A1, Exp 8/17/2022; b) 12012121A2, Exp 5/30/2022; 12212104A2, Exp 6/19/2022; 01242216A2, Exp 7/23/2022; 02182236A1, Exp 8/17/2022; c) 12072133A1, Exp 6/5/2022; 01192225A1, Exp 7/18/2022; 02182228A1, Exp 8/17/2022; d)10142105A, Exp 4/12/2022; 10272105A1, Exp 4/25/2022; 11102101A1, 11032120A2, Exp 4/30/2022; 11222116A2, Exp 5/21/2022; 12012121A2, Exp 5/30/2022; 12072132A1, Exp 6/5/2022; 12152110A1, Exp 6/13/2022; 12162118A1, Exp 6/14/2022; 12212103A2, Exp 6/19/2022; 01052206A1, Exp 7/4/2022; 01142229A1, Exp 7/13/2022; 01212207A2 Exp, 7/20/2022; 02042201A1, Exp 8/3/2022; 02182226A1, Exp 8/17/2022; 02252224A1, 02252226A1, Exp 8/24/2022.", "more_code_info": ""}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87298", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide in the USA and Puerto Rico.", "recall_number": "D-0272-2021", "product_description": "Desmopressin Acetate Injection USP, 4 mcg/mL, 1 mL Preserved Vial (NDC 0703-5051-01), packaged in 10X1 mL Vials per Tray (NDC 0703-5051-03), Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA  19454.", "product_quantity": "2,577 vials", "reason_for_recall": "Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.", "recall_initiation_date": "20210210", "center_classification_date": "20210221", "termination_date": "20240515", "report_date": "20210303", "code_info": "Lot # 31326669B, exp. date 03/2021"}, {"status": "Terminated", "city": "Research Triangle Park", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA211855"], "brand_name": ["VUMERITY"], "generic_name": ["DIROXIMEL FUMARATE"], "manufacturer_name": ["Biogen Inc."], "product_ndc": ["64406-020"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DIROXIMEL FUMARATE"], "rxcui": ["2261788", "2261794"], "spl_id": ["25e0bcfe-8df7-4a62-9db1-ba39a266e8bd"], "spl_set_id": ["2d74414f-6b83-4ea2-9a95-3cecabbce774"], "package_ndc": ["64406-020-01", "64406-020-03", "64406-020-05", "64406-020-07"], "is_original_packager": [true], "upc": ["0364406020032"], "unii": ["K0N0Z40J3W"]}, "product_type": "Drugs", "event_id": "86945", "recalling_firm": "Biogen MA Inc.", "address_1": "5000 Davis Dr", "address_2": "N/A", "postal_code": "27709", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0148-2021", "product_description": "Vumerity (diroximel fumarate) delayed-release capsule, 231 mg, packaged in  a) 106-count bottle, b)120-count bottle, Rx only, Manufactured for: Biogen Inc., Cambridge, MA 02142, NDC 64406-020-01", "product_quantity": "5,307 bottles", "reason_for_recall": "Failed dissolution specifications: out-of-specification test results observed during the buffer stage dissolution testing.", "recall_initiation_date": "20201209", "center_classification_date": "20201214", "termination_date": "20210917", "report_date": "20201223", "code_info": "Lot #: a) 101801, Exp 5/31/2021; 102826, Exp 6/21/2021; b) 101799, Exp 5/31/2021; 102362, Exp 6/21/2021"}, {"status": "Terminated", "city": "Largo", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77638", "recalling_firm": "VistaPharm, Inc.", "address_1": "7265 Ulmerton Rd", "address_2": "N/A", "postal_code": "33771-4809", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "CA, IL, LA, NH, OH, PA, SC", "recall_number": "D-1052-2017", "product_description": "Lactulose Solution, USP, 10 g/15 mL, dose cups delivers 15 mL packaged in 50-unit dose cups per case, Manufactured by VistaPharm, Inc., Largo, FL 33771,  NDC 66689-038-50", "product_quantity": "6150 cases", "reason_for_recall": "Microbial contamination of non-sterile product: product failed Total Yeast/Mold Count specification.", "recall_initiation_date": "20170626", "center_classification_date": "20170801", "termination_date": "20190403", "report_date": "20170809", "code_info": "Lot #: 468300, Exp 09/2018; 474400, Exp 11/2018"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-952-2015", "product_description": "Venlafaxine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "50 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Ongoing", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90566", "recalling_firm": "Family Dollar Stores, Llc.", "address_1": "500 Volvo Pkwy", "address_2": "", "postal_code": "23320-1604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1422-2022", "product_description": "READY IN CASE RUBBING ALCOHOL 91 PCT 16 FL  OZ\tSKU 902270   READY IN CASE 70 PCT ISOPROPYL ALCOHOL 32 FL OZ SKU 999747   READY IN CASE 91PCT ISOPROPYL ALCOHOL 32 FL OZ SKU 999742  READY IN CASE 70PCT ISOPROPYL ALCOHOL 16 FL OZ SKU 999743 distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.", "product_quantity": "Unknown", "reason_for_recall": "CGMP Deviations: product held outside appropriate storage temperature conditions.", "recall_initiation_date": "20220623", "center_classification_date": "20220822", "report_date": "20220831", "code_info": "SKUs: 902270; 999747; 999742; 999743", "more_code_info": ""}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0958-2020", "product_description": "Hydroxyprogesterone Caproate Injection, HYDROXYPROGESTERONE CAPROATE [4ML] 250 MG/ML INJECTABLE, For IV, IM Use, Refrigerate, 4 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0532-5", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 07302019+52772, Exp 2/25/2020"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M013"], "brand_name": ["ASPIRIN"], "generic_name": ["ASPIRIN"], "manufacturer_name": ["Rugby Laboratories"], "product_ndc": ["0536-1234"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["ASPIRIN"], "rxcui": ["308416"], "spl_id": ["8740c050-c1b4-4aba-b904-c950e0281a27"], "spl_set_id": ["63fcd93a-b1db-44ba-8f2b-055a7deb205d"], "package_ndc": ["0536-1234-41"], "is_original_packager": [true], "upc": ["0305361234416"], "nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "unii": ["R16CO5Y76E"]}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0170-2024", "product_description": "Low Dose ASPIRIN, 81 mg, 120 Enteric Coated Tablets, Distributed by: Rugby Lavoratories, 17177 N Laurel Park Drive, Suite 233, Livonia, MI 48152. NDC: 0536-1234-41", "product_quantity": "2 units", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch P126201", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; DARUNAVIR Tablet, 800 mg may be potentially mislabeled as    HYDROcodone BITARTRATE/ ACETAMINOPHEN, Tablet, 7.5 mg/325 mg, NDC 52544016201, Pedigree: W004005, EXP: 7/1/2014.", "address_2": "", "product_quantity": "90 Tablets", "code_info": "DARUNAVIR, Tablet, 800 mg has the following code    Pedigree: W003929, EXP: 7/1/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "DARUNAVIR Tablet, 800 mg, Rx only, Distributed by: AidaPak Service, LLC,  NDC 59676056630", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-641-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA208658"], "brand_name": ["SYNJARDY"], "generic_name": ["EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE"], "manufacturer_name": ["Boehringer Ingelheim Pharmaceuticals, Inc."], "product_ndc": ["0597-0280", "0597-0290", "0597-0295", "0597-0300"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["EMPAGLIFLOZIN", "METFORMIN HYDROCHLORIDE"], "rxcui": ["1862685", "1862688", "1862691", "1862692", "1862695", "1862697", "1862700", "1862701"], "spl_id": ["d7868c65-597e-4cc0-8fac-58f2c7bdb7be"], "spl_set_id": ["8006ba29-ee3a-f852-a9bb-c8ec9b41cf66"], "package_ndc": ["0597-0280-36", "0597-0280-73", "0597-0280-90", "0597-0290-20", "0597-0290-59", "0597-0290-74", "0597-0295-61", "0597-0295-78", "0597-0295-88", "0597-0300-20", "0597-0300-45", "0597-0300-93"], "is_original_packager": [true], "nui": ["N0000187059", "N0000187058"], "pharm_class_epc": ["Sodium-Glucose Cotransporter 2 Inhibitor [EPC]"], "pharm_class_moa": ["Sodium-Glucose Transporter 2 Inhibitors [MoA]"], "unii": ["HDC1R2M35U", "786Z46389E"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0459-2021", "product_description": "Synjardy XR (empagliflozin and metformin) hydrochloride extended-release) Tablets 12.5 mg/1000 mg 60 tablets Rx only NDC 0597-0300-45 Dist. by: Boehringer Ingelheim (BI) Pharmaceuticals, Inc. Ridgefield, CT 06877 USA", "product_quantity": "751 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "3190949"}, {"status": "Terminated", "city": "Ocala", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75289", "recalling_firm": "Wells Pharmacy Network LLC", "address_1": "1210 SW 33rd Ave", "address_2": "N/A", "postal_code": "34474-2853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0328-2017", "product_description": "ULTRA-TEST (CYP 80%/PROP 20%) Injectable, 250 mg/mL 10 mL vial, Compounded by Wells Pharmacy, Ocala, FL", "product_quantity": "157 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160921", "center_classification_date": "20170104", "termination_date": "20210702", "report_date": "20170111", "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry. Known Lot No. 03282016@22, 05162016@5, 07252016@16.    Known lot codes: 03282016@22, 05162016@5, 07262016@16"}, {"status": "Terminated", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72746", "recalling_firm": "Sentara Enterprises", "address_1": "535 Independence Pkwy Ste 300", "address_2": "N/A", "postal_code": "23320-5176", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "U.S. Including: VA, NC", "recall_number": "D-0627-2016", "product_description": "ASCORBIC ACID 500MG/Syringe, Packaged in 1ML Syringes, Rx Only. SENTARA HOME HEALTH SENTARA RX, 535 Independence Pkwy ste.300, Chesapeake, VA 23320-5176.", "product_quantity": "7 Syringes", "reason_for_recall": "Lack of Assurance of Sterility: Product sterility cannot be guaranteed.", "recall_initiation_date": "20150918", "center_classification_date": "20160128", "termination_date": "20160629", "report_date": "20160203", "code_info": "All Lots compounded between 11-Sep-15 and 17-Sep-15. Expiry: 27-Sep-15"}, {"status": "Ongoing", "city": "Berkeley Heights", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203088"], "brand_name": ["DULOXETINE"], "generic_name": ["DULOXETINE HYDROCHLORIDE"], "manufacturer_name": ["Quallent Pharmaceuticals Health, LLC"], "product_ndc": ["82009-029", "82009-030", "82009-032", "82009-031"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DULOXETINE HYDROCHLORIDE"], "rxcui": ["596926", "596930", "596934", "616402"], "spl_id": ["c7833be1-34d9-43e4-8aff-966c14aa2798"], "spl_set_id": ["31362045-201f-45f3-99f2-a5e322a0c30b"], "package_ndc": ["82009-029-05", "82009-030-10", "82009-032-10", "82009-031-30", "82009-031-90"], "is_original_packager": [true], "unii": ["9044SC542W"]}, "product_type": "Drugs", "event_id": "97336", "recalling_firm": "Breckenridge Pharmaceutical, Inc.", "address_1": "200 Connell Dr Ste 4200", "address_2": "N/A", "postal_code": "07922-2805", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NJ, AZ, IN", "recall_number": "D-0580-2025", "product_description": "Duloxetine Delayed-Release Capsules, USP, 60 mg, 1,000 Capsules per bottle, Rx Only, Manufactured by: Towa Pharmaceutical Europe, S.L., Martorelles, (Barcelona), Spain.  Manufactured for: Quallent Pharmaceuticals Health LLC, Grand Cayman, Cayman Islands. NDC  82009-032-10", "product_quantity": "1,856 bottles", "reason_for_recall": "CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.", "recall_initiation_date": "20250725", "center_classification_date": "20250812", "report_date": "20250820", "code_info": "Lot 240539C, Exp 1/31/2027", "more_code_info": ""}, {"status": "Terminated", "city": "Camarillo", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "74847", "recalling_firm": "Golden State Medical Supply Inc.", "address_1": "5187 Camino Ruiz", "address_2": "N/A", "postal_code": "93012-8601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1458-2016", "product_description": "Venlafaxine Hydrochloride Extended-Release Capsules, 150 mg, a) 30 capsules per bottle, NDC # 60429-123-30, b) 90 capsules per bottle, NDC # 60429-123-90, Rx Only, GSMS.", "product_quantity": "65,401 bottles", "reason_for_recall": "Failed Dissolution Specifications: Out-of-specification results in retained sample.", "recall_initiation_date": "20160803", "center_classification_date": "20160816", "termination_date": "20170202", "report_date": "20160824", "code_info": "Lot #: a) GS011931,  Exp 10/2017; GS011932, Exp 11/2017  b) GS010773, GS011242, 09/2017; GS011061, GS011315, GS011357,   GS011585, GS011586, GS011588, GS011591, Exp 10/2017; GS011933, Exp 11/2017"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0576-2019", "product_description": "Dr. King's Natural Medicine Homeopathic Artery, Cholesterol & BP, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806, UPC 357955506423, NDC 57955-5064-2", "product_quantity": "1249 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lot Numbers: 050216C Exp. 07/19; 071316K Exp. 05/19"}, {"status": "Terminated", "city": "Sharm", "state": "", "country": "United Arab Emirates", "classification": "Class III", "openfda": {"application_number": ["ANDA078866"], "brand_name": ["BUPROPION HYDROCHLORIDE"], "generic_name": ["BUPROPION HYDROCHLORIDE"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["47335-736", "47335-737", "47335-738"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["BUPROPION HYDROCHLORIDE"], "rxcui": ["993503", "993518", "993536"], "spl_id": ["b8e6ae63-c5d7-4481-b7b0-17e135670515"], "spl_set_id": ["29848192-7de3-4c0d-a822-1268dcf128b0"], "package_ndc": ["47335-736-86", "47335-736-88", "47335-736-08", "47335-736-13", "47335-737-86", "47335-737-88", "47335-737-08", "47335-737-13", "47335-738-86", "47335-738-88", "47335-738-08", "47335-738-13"], "is_original_packager": [true], "upc": ["0347335738865", "0347335737868"], "unii": ["ZG7E5POY8O"]}, "product_type": "Drugs", "event_id": "71949", "recalling_firm": "Sun Pharma Global Fze", "address_1": "Office # 43 Block Y Saif Zone", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1345-2015", "product_description": "buPROPion Hydrochloride Extended-\u00bfrelease Tablets USP  (SR), 200 mg, Twice-A-Day, Rx Only, 60 count Bottle, Distributed by: Sun Pharmaceutical Industries Inc. Cranbury, NJ 08512, Manufactured By: Sun Pharmaceutical Ind. Ltd., Halol Baroda Highway, Halol 389 350, Gujarat, India, NDC 47335-738-86", "product_quantity": "35,235 bottles", "reason_for_recall": "Failed Dissolution Specification: During analysis of the 18 month long term stability testing, it was noticed that the drug release results at the 4 hour time point are not meeting specifications.", "recall_initiation_date": "20150717", "center_classification_date": "20150814", "termination_date": "20160322", "report_date": "20150826", "code_info": "Lot #s: JKM4152A, JKM4737A, JKM5270A, Exp 08/2015", "more_code_info": ""}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73925", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-0075-2017", "product_description": "midazolam HCl, 1 mg per mL (2 mg per 2 mL), in 0.9% Sodium Chloride, 2 mL Total Volume in a syringe, For IV Use, Rx only, PharMEDium, Product code 2R3356.", "product_quantity": "26079 syringes", "reason_for_recall": "Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.", "recall_initiation_date": "20150717", "center_classification_date": "20161012", "termination_date": "20170623", "report_date": "20161019", "code_info": "Lot Numbers: 151170045M, 151170084M, 151170093M, 15117084M, 151180080M, 15118092M, 15118094M, 15119054M, 15120072M, 15121093M, 151240093M, 151240094M, 151240099M, 15124074M, 151250094M, 15126044M, 15126079M, 15126080M, 15127097M, 15127098M, 15128112M, 151310092M, 151310103M, 151310105M, 15131028M, 151320099M, 15133012M, 15133081M, 15134068M,15134069M, 151380068M, 151380106M,  151380112M, 151390138M, 15139090M, 15140088M, 15140089M, 15141045M, 15141074M, 15141075M, 151450030M, 151450032M, 151460097M, 15146083M, 15146087M, 15149001M, 15149005M, 15149118M, 15149119M, 15150104M, 15152056M, 151720012M,   151730078M, 151730138M, 151740019M, 151740141M, 151740143M, 151890127M, 151890128M, 151890305M, 151900021M, 151900022M, 151900140M, 151930073M, 151930171M, 151930173M, Exp between 07/15/15-10/12/15"}, {"status": "Terminated", "city": "Little Rock", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73899", "recalling_firm": "Baptist Health Medical Towers Pharmacy and Infusion Services", "address_1": "9601 Baptist Health Dr Ste 109", "address_2": "N/A", "postal_code": "72205-6323", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Arkansas", "recall_number": "D-0915-2016", "product_description": "Cefazolin 6 grams in 292 mL 0.9% NS bags, FOR IV USE ONLY, Baptist Health Medical Towers Pharmacy & Infusion, Little Rock, Arkansas", "product_quantity": "11 bags", "reason_for_recall": "Lack of Sterility Assurance", "recall_initiation_date": "20160418", "center_classification_date": "20160529", "termination_date": "20161223", "report_date": "20160608", "code_info": "All product remaining within expiry"}, {"country": "United States", "city": "Federal Way", "address_1": "530 S 336th St", "reason_for_recall": "Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.", "address_2": "", "product_quantity": "4 vials", "code_info": "Lot # t11-28-2016@86, Exp 5/22/2017; t12-19-2016@73, Exp 5/22/2017", "center_classification_date": "20170517", "distribution_pattern": "Distributed nationwide in U.S.A.,  Australia and Canada.", "state": "WA", "product_description": "PGE1/PROCAINE 5ML MDV 40MCG/ML/0.1% INJ, Injection, 40mcg/mL, 0.1%, Rx only, 5 mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy", "report_date": "20170524", "classification": "Class II", "openfda": {}, "recalling_firm": "Key Pharmacy and Compounding Center", "recall_number": "D-0757-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "76912", "termination_date": "20170829", "more_code_info": "", "recall_initiation_date": "20170418", "postal_code": "98003-6383", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Tampa", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76714", "recalling_firm": "Signature Club A Ltd", "address_1": "550 N Reo St Ste 300", "address_2": "N/A", "postal_code": "33609-1037", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0662-2017", "product_description": "Double Hyaluronic 1000, 'AN OUNCE OF GOLD' Volumizing Day Cream, Broad Spectrum SPF 30+, (Octinoxate 7.725%, Oxybenzone 6.18%, Octisalate 5.15%, Avobenzone 3.09%), Net Wt. 1.8 oz. (51 g) jar, Distributed by Signature Club A, Ltd, Tampa, FL 33609.", "product_quantity": "1,237 jars", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: odor complaint of product due to microbial contamination.", "recall_initiation_date": "20170301", "center_classification_date": "20170412", "report_date": "20170419", "code_info": "Lot #: 1626253/1746. Exp 10/18", "more_code_info": ""}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "79635", "recalling_firm": "Akorn, Inc.", "address_1": "1925 W Field Ct Ste 300", "address_2": "", "postal_code": "60045-4862", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0613-2018", "product_description": "24-HOUR Oral Care q4 Kit with Ballard* Technology, containing 2 Toothbrush Packs with CHG Solution, Chlorhexidine Gluconate Oral Rinse, 0.12%, 15 mL unit dose cup (NDC 50383-720-15), Rx Only, Hi-Tech Pharmacal Co., Inc. Amityville, NY 11701; Kit Manufactured by Halyard Health, Inc., 5405 Windward Parkway, Alpharetta, GA  30004; Distributed in the USA by Halyard Sales, LLC, Alpharetta, GA 30004, Product 97014.", "product_quantity": "20,587 unit dose cups", "reason_for_recall": "Subpotent Drug: Product crystallization with accompanying low out of specification results for chlorhexidine assay.", "recall_initiation_date": "20180329", "center_classification_date": "20180329", "termination_date": "20200422", "report_date": "20180404", "code_info": "Chlorhexidine Gluconate Oral Rinse lot # 350836, Exp 05/18 contained within kit lot #: 0202522468, 0202522470, Exp 03/18; 0202518966, 0202522469, 0202522471, 0202533449, 0202533456, 0202533463, 0202543351, 0202548200, Exp 04/18", "more_code_info": ""}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0209-2022", "product_description": "TRI-MIX PAPAVERINE 30/PHENTOLAMINE 1/PGE-1 40 INJ   INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "4 vials", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: 07272021:15 BUD: 11/30/2021; 07122021:11 BUD: 10/23/2021", "more_code_info": ""}, {"status": "Ongoing", "city": "Massena", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M012"], "brand_name": ["OXYMETAZOLINE HYDROCHLORIDE"], "generic_name": ["OXYMETAZOLINE HYDROCHLORIDE"], "manufacturer_name": ["CHAIN DRUG MARKETING ASSOCIATION INC."], "product_ndc": ["63868-605", "63868-676"], "product_type": ["HUMAN OTC DRUG"], "route": ["NASAL"], "substance_name": ["OXYMETAZOLINE HYDROCHLORIDE"], "rxcui": ["1000990"], "spl_id": ["3446fcd3-f2b4-4f5f-b80e-f0600b7efc81"], "spl_set_id": ["c7b1f980-9b0d-4f63-a70d-fd366658f863"], "package_ndc": ["63868-605-01", "63868-676-01"], "is_original_packager": [true], "upc": ["0635515988439", "0635515988477", "635515988477"], "unii": ["K89MJ0S5VY"]}, "product_type": "Drugs", "event_id": "93708", "recalling_firm": "Seaway Pharma Inc.", "address_1": "5 County Route 42", "address_2": "N/A", "postal_code": "13662-1569", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "MI, PA", "recall_number": "D-0216-2024", "product_description": "Quality Choice No Drip Extra Moisturizing Nasal Pump Mist Oxymetazoline hydrochloride 0.05%, 12 Hour Nasal Decongestant, 1 fl oz (30 mL) bottle, Distributed by C.D.M.A, Inc. 43157 W 9 Mile Rd. Novi, MI 48375, NDC# 63868-676-01, UPC 6-35515-98847-7.", "product_quantity": "7,992 bottles", "reason_for_recall": "CGMP Deviations: Firm reported possible microbial contamination in the purified water used in the manufacturing of the products. No contamination was found in the final products.", "recall_initiation_date": "20231228", "center_classification_date": "20240104", "report_date": "20240110", "code_info": "Lot # SE23034, Exp 05/31/2026"}, {"status": "Terminated", "city": "Indianapolis", "state": "IN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80703", "recalling_firm": "Northwind Pharmaceuticals LLC", "address_1": "9402 Uptown Dr Ste 1100", "address_2": "", "postal_code": "46256-1042", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Indiana", "recall_number": "D-1098-2018", "product_description": "Valsartan, 320mg, 30 tablets per bottle, Rx Only, Repackaged By: Northwind Pharmaceuticals, Indianapolis, IN 46256. NDC: 51655-0654-52", "product_quantity": "14 bottles", "reason_for_recall": "CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.", "recall_initiation_date": "20180718", "center_classification_date": "20180815", "termination_date": "20230325", "report_date": "20180822", "code_info": "Lot: UT48100001, exp 9/30/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80118", "recalling_firm": "Guardian Pharmacy Services", "address_1": "7920 Elmbrook Dr Ste 108", "address_2": "N/A", "postal_code": "75247-4933", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Texas", "recall_number": "D-1073-2018", "product_description": "Phenol 6% with Glycerin Inj 10 ml. Packaged in 10 ml vials. Compounded Guardian Pharmacy Services, 7920 Elmbrook Dr. Ste. 108C Dallas TX 75247", "product_quantity": "40 10-ml vials", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20180517", "center_classification_date": "20180808", "termination_date": "20201125", "report_date": "20180815", "code_info": "Lots: 58913:42 Use By: 06/05/2018"}, {"status": "Terminated", "city": "Southfield", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65876", "recalling_firm": "Beacon Hill Medical Pharmacy, P.C.", "address_1": "18161 W 13 Mile Rd", "address_2": "Suite A1", "postal_code": "48076-1113", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "USA nationwide", "recall_number": "D-991-2013", "product_description": "PROG/TEST CYP 15/7.5 MG/ML OIL INJ SOLN, all presentations, FOR INTRAVENO AND SQ USE ONLY, STERILE, RX ONLY, Compounded by Beacon Hill Medical Pharmacy PC, dba Rxtra Solutions, Southfield, MI", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance", "recall_initiation_date": "20130726", "center_classification_date": "20130910", "termination_date": "20140718", "report_date": "20130918", "code_info": "05012013@23, 06202013@20", "more_code_info": ""}, {"status": "Terminated", "city": "Ocala", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75289", "recalling_firm": "Wells Pharmacy Network LLC", "address_1": "1210 SW 33rd Ave", "address_2": "N/A", "postal_code": "34474-2853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0332-2017", "product_description": "MIC Combo - Standard 15 mg/50 mg/100 mg/mL Injectable, 30 mL vials, Compounded by Wells Pharmacy, Ocala, FL", "product_quantity": "308 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160921", "center_classification_date": "20170104", "termination_date": "20210702", "report_date": "20170111", "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry.     Known lot code: 03292016@5, 04122016@76, 04202016@5, 05182016@2, 06102016@2, 06282016@71, 09092016@1"}, {"status": "Terminated", "city": "Palm Harbor", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81810", "recalling_firm": "Promise Pharmacy, LLC", "address_1": "31818 Us Highway 19 N", "address_2": "N/A", "postal_code": "34684-3713", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0457-2019", "product_description": "Epithalon, 15mg injection, Rx Only, Promise Pharmacy Compounding Specialists 31818 US Hwy 19N, Palm Harbor, FL 34684", "product_quantity": "30 vials", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20181217", "center_classification_date": "20190208", "termination_date": "20210330", "report_date": "20190220", "code_info": "Lots: 09212018@11 BUD: 12/20/2018; 11132018@4 BUD: 2/11/2019"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-744-2015", "product_description": "Ketotifen Fumarate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "100 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078906"], "brand_name": ["VERAPAMIL HYDROCHLORIDE"], "generic_name": ["VERAPAMIL HYDROCHLORIDE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-260", "68462-292", "68462-293"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["VERAPAMIL HYDROCHLORIDE"], "rxcui": ["897640", "897649", "897659"], "spl_id": ["d1db2ec0-ce9d-4f3a-a2ca-c85b752a09a7"], "spl_set_id": ["ba1bf1ae-9347-4d17-998b-14bf7b5984ce"], "package_ndc": ["68462-292-90", "68462-292-01", "68462-292-05", "68462-293-90", "68462-293-01", "68462-293-05", "68462-260-30", "68462-260-90", "68462-260-01", "68462-260-05", "68462-260-10"], "is_original_packager": [true], "upc": ["0368462292013", "0368462260012", "0368462293010", "074301920558"], "unii": ["V3888OEY5R"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0483-2021", "product_description": "Verapamil Hydrochloride Extended-Release Tablets USP 120 mg Rx Only NDC 68462-292-01 Manufactured by: Glenmark Generics Ltd Colvale-Bardez, Goa 403513, India  Manufactured for: Glenmark Generics Inc., USA Mahwah, NJ 07430", "product_quantity": "513 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "19205584"}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0197-2022", "product_description": "TRI-MIX PAPAVERINE 26/PHENTOLAMINE 3/PGE-1 60/ML INJ   INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "1 vial", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: 08192021:32 BUD: 02/15/2022", "more_code_info": ""}, {"country": "United States", "city": "Orlando", "address_1": "6700 Conroy Windermere Rd", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes", "address_2": "Suite 140", "product_quantity": "1", "code_info": "C5428 Exp 9/4/13", "center_classification_date": "20130711", "distribution_pattern": "Nationwide and PR", "state": "FL", "product_description": "Fluphenazine 25 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL", "report_date": "20130717", "classification": "Class II", "openfda": {}, "recalling_firm": "Lowlite Investments, Inc. D/B/A Olympia Pharmacy", "recall_number": "D-729-2013", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "65360", "recall_initiation_date": "20130529", "postal_code": "32835-3500", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77191", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0915-2017", "product_description": "VANCOMYCIN HCl 1.75g in 300 mL 0.9% Sodium Chloride Injection USP, Service Code 2K2237, NDC# 61553-037-34, Total Volume 300.00 mL incorrectly labeled as 500.00 mL, Rx Only, PharMEDium Services, LLC, 12620 W. Airport Blvd #130, Sugar Land, TX 74478", "product_quantity": "60 bags", "reason_for_recall": "Labeling: Not Elsewhere Classified: Incorrect volume printed on the product label.", "recall_initiation_date": "20170217", "center_classification_date": "20170612", "termination_date": "20170613", "report_date": "20170621", "code_info": "Lot Numbers:  170160016S, 2/20/2017; 170240147S, 3/1/2017; 170380016S, 3/15/2017; 170450010S, 3/22/2017"}, {"status": "Terminated", "city": "Highland", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89334", "recalling_firm": "ULTRAtab Laboratories, Inc.", "address_1": "50 Toc Dr", "address_2": "N/A", "postal_code": "12528-1506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Bulk product was distributed to 3 distributors who may have distributed finished product.", "recall_number": "D-0552-2022", "product_description": "Legatrin (Acetaminophen 500 mg, Diphenhydramine HCl 50 mg) Bulk Container, ULTRAtab Laboratories, Inc., Highland, NY  NDC 62959-785-00", "product_quantity": "14,066,434 tablets", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20220126", "center_classification_date": "20220209", "termination_date": "20250107", "report_date": "20220216", "code_info": "Product Codes: M785L  Bulk Lots: 18K029, 18L059, 18M100, 19B013, 19D024, 19D059, 19E029, 19J050"}, {"country": "United States", "city": "Camarillo", "address_1": "768 Calle Plano # B", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: Fusion Pharmaceuticals is recalling the Dicopanol FusePaq Kit due to Total Yeasts and Molds Count above USP limits.", "address_2": "", "product_quantity": "1,200 kits", "code_info": "Lots: PL520, PL521, PL522 and PL523", "center_classification_date": "20140131", "distribution_pattern": "CA", "state": "CA", "product_description": "Dicopanol FusePaq Kit for Oral Suspension, 5mg/ML", "report_date": "20140212", "classification": "Class II", "openfda": {}, "recalling_firm": "Fusion Pharmaceuticals, LLC", "recall_number": "D-1055-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "66139", "termination_date": "20140131", "more_code_info": "", "recall_initiation_date": "20130508", "postal_code": "93012-8555", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Orlando", "address_1": "6700 Conroy Windermere Rd", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes", "address_2": "Suite 140", "product_quantity": "1", "code_info": "C5822 Exp 9/8/13", "center_classification_date": "20130711", "distribution_pattern": "Nationwide and PR", "state": "FL", "product_description": "Sodium Iodide 20% Injection, compounded by Olympia Pharmacy, Orlando, FL", "report_date": "20130717", "classification": "Class II", "openfda": {}, "recalling_firm": "Lowlite Investments, Inc. D/B/A Olympia Pharmacy", "recall_number": "D-780-2013", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "65360", "recall_initiation_date": "20130529", "postal_code": "32835-3500", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"status": "Terminated", "city": "Camarillo", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {"brand_name": ["SNORESTOP NASOSPRAY 60"], "generic_name": ["STRYCHNOS NUX-VOMICA SEED,ATROPA BELLADONNA,EPHEDRA DISTACHYA FLOWERING TWIG,GOLDENSEAL,POTASSIUM DICHROMATE,TEUCRIUM MARUM,HISTAMINE DIHYDROCHLORIDE LIQUID"], "manufacturer_name": ["Green Pharmaceuticals Inc."], "product_ndc": ["61152-199"], "product_type": ["HUMAN OTC DRUG"], "route": ["NASAL"], "substance_name": ["ATROPA BELLADONNA", "EPHEDRA DISTACHYA FLOWERING TWIG", "GOLDENSEAL", "N.ALPHA.-METHYLHISTAMINE DIHYDROCHLORIDE", "POTASSIUM DICHROMATE", "STRYCHNOS NUX-VOMICA SEED", "TEUCRIUM MARUM"], "spl_id": ["e194696f-0a7f-f303-e053-2a95a90a3c90"], "spl_set_id": ["f4d26053-32aa-4cc9-8460-556acc38fe33"], "package_ndc": ["61152-199-99"], "is_original_packager": [true], "nui": ["N0000185375", "N0000175629", "N0000184306", "N0000185001", "M0000728", "M0016962", "M0516536"], "pharm_class_epc": ["Non-Standardized Plant Allergenic Extract [EPC]"], "pharm_class_pe": ["Increased Histamine Release [PE]", "Cell-mediated Immunity [PE]", "Increased IgG Production [PE]"], "pharm_class_cs": ["Allergens [CS]", "Plant Proteins [CS]", "Seed Storage Proteins [CS]"], "unii": ["WQZ3G9PF0H", "R55VQ87DP3", "ZW3Z11D0JV", "S6S98U0517", "T4423S18FM", "269XH13919", "10464S0TAA"], "upc": ["769682291013"]}, "product_type": "Drugs", "event_id": "90384", "recalling_firm": "Green Pharmaceuticals, Inc.", "address_1": "591 Constitution Ave Ste A", "address_2": "", "postal_code": "93012-9106", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1165-2022", "product_description": "SnoreStop NasoSpray, 0.3 FL OZ (9 mL), Green Pharmaceuticals Inc. Camarillo, CA 93012, NDC 61152-199-99, UPC 7 69682 29101 3", "product_quantity": "1074 spray bottles", "reason_for_recall": "Microbial contamination of non-sterile product: FDA laboratory analysis found product to contain microbial contamination identified as Providencia rettgeri.", "recall_initiation_date": "20220609", "center_classification_date": "20220627", "termination_date": "20230414", "report_date": "20220706", "code_info": "Lot #: 2373/21222", "more_code_info": ""}, {"status": "Terminated", "city": "Karodi", "state": "", "country": "India", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "80356", "recalling_firm": "Wockhardt Limited", "address_1": "H - 14/2 Plot", "address_2": "Biotech Park", "postal_code": "N/A", "voluntary_mandated": "", "initial_firm_notification": "", "distribution_pattern": "Nationwide.", "recall_number": "D-0912-2018", "product_description": "Enalapril Maleate Tablets USP; 5 mg NDC code 64679-924-03. 1000 Tablets HDPE container pack with Non CRC cap and 2 desiccants further packed in E-flute cartons.", "product_quantity": "31,710 tablets", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20180619", "center_classification_date": "20180709", "termination_date": "20200413", "report_date": "20180718", "code_info": "Batch# DR10445 (Exp: 4/19); Batch# DR10637 (Exp: 5/19); Batch# DR10646 (Exp: 5/19); Batch# DR10647 (Exp: 5/19); Batch# DR10725 (Exp: 7/19); Batch# DR10755 (Exp: 7/19); Batch# DR10811 (Exp: 9/19); Batch# DS10040 (Exp: 12/19); Batch# DS10041 (Exp: 12/19); Batch# DS10024 (Exp: 12/19); and Batch# DS10048 (Exp: 12/19).", "more_code_info": ""}, {"status": "Terminated", "city": "Rocky Mount", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA018667"], "brand_name": ["FUROSEMIDE"], "generic_name": ["FUROSEMIDE"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-6102"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["FUROSEMIDE"], "rxcui": ["1719286", "1719290", "1719291"], "spl_id": ["0d4a39f2-904e-434a-9af1-83bb4febf124"], "spl_set_id": ["39fd32f2-6bb7-4a65-d298-e48d26bc80c7"], "package_ndc": ["0409-6102-19", "0409-6102-02", "0409-6102-18", "0409-6102-04", "0409-6102-20", "0409-6102-10"], "is_original_packager": [true], "nui": ["N0000175366", "N0000175590"], "pharm_class_pe": ["Increased Diuresis at Loop of Henle [PE]"], "pharm_class_epc": ["Loop Diuretic [EPC]"], "unii": ["7LXU5N7ZO5"]}, "product_type": "Drugs", "event_id": "64083", "recalling_firm": "Hospira, Inc.", "address_1": "Hwy. 301 N. + 4285 North Wesleyan Blvd.", "address_2": "N/A", "postal_code": "27804", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-169-2013", "product_description": "Furosemide Injection USP (10 mg/mL), 4 mL in 5 mL Fliptop Vial, Rx only, Hospira Inc., Lake Forest, IL --- NDC 0409-6102-04", "product_quantity": "63,900 vials", "reason_for_recall": "Lack of Assurance of Sterility; possible loose crimp applied to fliptop vial", "recall_initiation_date": "20130110", "center_classification_date": "20130226", "termination_date": "20141008", "report_date": "20130306", "code_info": "18-099-DK"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93103", "recalling_firm": "Central Admixture Pharmacy Services Inc", "address_1": "7935 Dunbrook Rd Ste C", "address_2": "N/A", "postal_code": "92126-6322", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0009-2024", "product_description": "fentaNYL in 0.9% sodium chloride, 10 mcg/1 mL, (10 mcg/mL), 3 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C San Diego, CA 92126, NDC: 71286-2071-1", "product_quantity": "1,767 3 mL syringes", "reason_for_recall": "Lack of assurance of sterility:", "recall_initiation_date": "20230921", "center_classification_date": "20231004", "termination_date": "20250319", "report_date": "20231011", "code_info": "Lot: 17-275621, Exp. 10/8/2023; 17-275693, 17-275725, Exp. 10/9/2023"}, {"country": "United States", "city": "Horsham", "address_1": "425 Privet Rd", "reason_for_recall": "CGMP Deviations", "address_2": "", "product_quantity": "92,480 containers", "code_info": "All Lots Within Expiry", "center_classification_date": "20160907", "distribution_pattern": "Nationwide and Puerto Rico", "state": "PA", "product_description": "Linezolid Injection 600 mg/300 mL Rx Only, Manufactured in Hungary for TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, NDC#  0703-9060-31- (Single Use Container), NDC# 0703-9060-33 (Box of 10 Singe Use Containers)", "report_date": "20160914", "classification": "Class II", "openfda": {}, "recalling_firm": "Teva North America", "recall_number": "D-1495-2016", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "74497", "termination_date": "20170207", "more_code_info": "", "recall_initiation_date": "20160617", "postal_code": "19044-1220", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "New Paltz", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89464", "recalling_firm": "Ultra Seal Corporation", "address_1": "521 Main St", "address_2": "N/A", "postal_code": "12561-1609", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0504-2022", "product_description": "PEPTIME Energy (caffeine 250mg) tablets, packaged in a) 6 count packets and b) 100-count bottles, Marketed by: DMD Pharmaceuticals, A Division of Dickery Consumer Products, Inc., Noblesville, IN 46060.", "product_quantity": "a) 156,096 packets, b) 9,648 bottles", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20220124", "center_classification_date": "20220131", "termination_date": "20231016", "report_date": "20220209", "code_info": "Lot #: a)19E021, b)19E022"}, {"country": "United States", "city": "Garland", "address_1": "3309 W Kingsley Rd", "reason_for_recall": "Subpotent (Single Ingredient Drug): The firm is recalling the product because the product is subpotent and does not meet the labeled 0.25% zinc pyrithione level.", "address_2": "", "product_quantity": "4800 bottles", "code_info": "Lot 022110-01", "center_classification_date": "20120614", "distribution_pattern": "Maine", "state": "TX", "product_description": "DermaZinc Spray, 0.25% zinc pyritione, topical  OTC, 4 fl oz bottle Distributed By: Dermallogix Partners, Inc. Scarborough, ME 04070", "report_date": "20120620", "classification": "Class III", "openfda": {}, "recalling_firm": "Quadrant Chemical Corporation", "recall_number": "D-1380-2012", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "61518", "termination_date": "20120913", "more_code_info": "", "recall_initiation_date": "20120320", "postal_code": "75041-2207", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Moon Township", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M022"], "brand_name": ["SENSODYNE COMPLETE PROTECTION"], "generic_name": ["STANNOUS FLUORIDE"], "manufacturer_name": ["Haleon US Holdings LLC"], "product_ndc": ["0135-0572", "0135-0573"], "product_type": ["HUMAN OTC DRUG"], "route": ["DENTAL"], "substance_name": ["STANNOUS FLUORIDE"], "rxcui": ["416784"], "spl_id": ["78b76a64-361a-41e8-aead-29ac143c0901"], "spl_set_id": ["e3cc3146-8aed-4f6b-a252-e379418c2b8d"], "package_ndc": ["0135-0573-02", "0135-0573-03", "0135-0572-02", "0135-0572-03"], "is_original_packager": [true], "unii": ["3FTR44B32Q"]}, "product_type": "Drugs", "event_id": "71750", "recalling_firm": "GlaxoSmithkline Consmer Healthcare", "address_1": "1000 GSK Drive", "address_2": "N/A", "postal_code": "15108", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide, Puerto Rico & Taiwan", "recall_number": "D-1322-2015", "product_description": "SENSODYNE COMPLETE PROTECTION, 3.4 oz. (96.4 g)tubes, Manufactured by Oratech, South Jordan UTAH 84095, Distributed by GlaxoSmithKline, Consumer Healthcare, L.P., Moon Township, PA 15108,  NDC 0135-0573-02", "product_quantity": "81,376 tubes", "reason_for_recall": "Presence of Foreign Substance: Fragments of wood found when the product was extruded onto a toothbrush.", "recall_initiation_date": "20150715", "center_classification_date": "20150811", "termination_date": "20170419", "report_date": "20150819", "code_info": "Lot #    B4D031, Exp 03/16  B4E101, Exp 04/16  B4F261,B4F291,B4G011, Exp 05/16  B4G031, B4G091, Exp 06/16  B4J031, Exp 07/16"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA211061"], "brand_name": ["HALOPERIDOL"], "generic_name": ["HALOPERIDOL"], "manufacturer_name": ["Upsher-Smith Laboratories, LLC"], "product_ndc": ["0832-1510", "0832-1520", "0832-1530", "0832-1540", "0832-1550", "0832-1560"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["HALOPERIDOL"], "rxcui": ["197754", "310670", "310671", "310672", "314034", "314035"], "spl_id": ["326f5ed0-bc46-a1f5-e063-6394a90af2c1"], "spl_set_id": ["afb3ac3e-7459-42d3-b5ca-e0d6d27ced73"], "package_ndc": ["0832-1510-11", "0832-1520-11", "0832-1520-89", "0832-1520-01", "0832-1530-11", "0832-1540-11", "0832-1540-89", "0832-1540-01", "0832-1550-11", "0832-1550-89", "0832-1550-01", "0832-1560-11"], "is_original_packager": [true], "upc": ["0308321510117", "0308321530115", "0308321550113", "0308321560112", "0308321520116", "0308321540114"], "nui": ["N0000180182"], "pharm_class_epc": ["Typical Antipsychotic [EPC]"], "unii": ["J6292F8L3D"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0593-2021", "product_description": "HALOPERIDOL TABLETS 20mg, USP, 100-count bottle, Rx Only Distributed by: Usher-Smith Laboratories, LLC, Maple Grove, MN 55369, NDC: 0832-1560-11", "product_quantity": "35 BOTTLE", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "2007346C"}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92253", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0746-2023", "product_description": "heparin added to 0.9% sodium chloride, 2,500 units/500 mL* (5 units/mL), 500 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA  18106, NDC 71285-8100-1.", "product_quantity": "2992 bags", "reason_for_recall": "Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.", "recall_initiation_date": "20230428", "center_classification_date": "20230519", "termination_date": "20250622", "report_date": "20230531", "code_info": "Lot # 37-888833, Exp 05/02/2023; 37-890537, Exp 05/09/2023; 37-892161, 37-892163, Exp 05/16/2023; 37-893979, 37-893992, Exp 05/23/2023; 37-895755, 37-895758, Exp 05/30/2023"}, {"status": "Terminated", "city": "Scott", "state": "LA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78669", "recalling_firm": "Intrathecal Compounding Specialist, LLC", "address_1": "206 Jacobs Run", "address_2": "N/A", "postal_code": "70583-8907", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0321-2018", "product_description": "All sterile drug preparations remaining within expiry prepared from Hydromorphone Base Solution dispensed between October 16, 2017 and November 17, 2017, Compounded by Intrathecal Compounding Specialists, Scott, LA 70583.", "product_quantity": "Unknown", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20171130", "center_classification_date": "20180204", "termination_date": "20190501", "report_date": "20180214", "code_info": "All lots remaining within expiry (BUDs between November 15, 2017 and December 16, 2017)."}, {"status": "Terminated", "city": "Overland Park", "state": "KS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69674", "recalling_firm": "Perry Drug Inc.", "address_1": "12200 W 106th St Ste 140", "address_2": "N/A", "postal_code": "66215-2305", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Kansas and Missouri", "recall_number": "D-0274-2015", "product_description": "HCG - 10,000 Unit PF Inject, 1mL Syringe, Compounded Rx, Perry Drug Compounding Pharmacy, Overland Park, KS NDC 88888-0216-49", "product_quantity": "1 vial", "reason_for_recall": "Lack of sterility assurance;All lots of sterile products compounded by the pharmacy that are within expiry were recalled due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "recall_initiation_date": "20141107", "center_classification_date": "20141124", "termination_date": "20151103", "report_date": "20141203", "code_info": "141021CC, 11/21/14", "more_code_info": ""}, {"status": "Ongoing", "city": "Amman", "state": "", "country": "Jordan", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92974", "recalling_firm": "AMMAN PHARMACEUTICAL INDUSTRIES", "address_1": "Building 108", "address_2": "Street A3, King Abdullah Ii Industrial City", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to two (2) direct accounts in RI and CO.", "recall_number": "D-1151-2023", "product_description": "TRP Natural Eyes, Aging Eye Relief, Sterile Eye Drops, Homeopathic 0.33 FL OZ (10 mL), Manufactured in Jordan, exclusively for TRP Company, Inc., 1575 Delucchi Lane, Reno, NV 89502 NDC: 17312-027-15.", "product_quantity": "8,747 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20230901", "center_classification_date": "20230915", "report_date": "20230927", "code_info": "Lot#:DB001 EXP: 06/24", "more_code_info": ""}, {"status": "Terminated", "city": "Tulsa", "state": "OK", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71618", "recalling_firm": "The Apothecary Shoppe LLC", "address_1": "6136 E 51st St", "address_2": "N/A", "postal_code": "74135-7704", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Oklahoma", "recall_number": "D-1316-2015", "product_description": "S-Methylcobalamin 5000 mcg/mL Inj., Rx Only, 750 mL Container, Apothecary Shoppe, Compounding Pharmacy, Tulsa OK 74135", "product_quantity": "750 mL", "reason_for_recall": "Lack of Assurance of Sterility: Due to lack of documentation of proper environmental monitoring during the time in which the medication was produced.", "recall_initiation_date": "20150626", "center_classification_date": "20150806", "termination_date": "20170217", "report_date": "20150812", "code_info": "Lot #: 05012015@4, BUD 10/28/2015"}, {"status": "Ongoing", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA213368"], "brand_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "generic_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "manufacturer_name": ["Northstar Rx LLC"], "product_ndc": ["16714-047", "16714-048", "16714-049", "16714-050", "16714-051"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "rxcui": ["991039", "991044", "991188", "991194", "991336"], "spl_id": ["13fe8f97-37e8-4d10-87fe-e1d17f4f23d8"], "spl_set_id": ["2bd42d3a-bf89-4d74-a252-9b914106a570"], "package_ndc": ["16714-047-01", "16714-048-01", "16714-049-01", "16714-050-01", "16714-051-01"], "is_original_packager": [true], "unii": ["9WP59609J6"]}, "product_type": "Drugs", "event_id": "97534", "recalling_firm": "Zydus Pharmaceuticals (USA) Inc", "address_1": "73 Route 31 N", "address_2": "N/A", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0633-2025", "product_description": "Chlorpromazine Hydrochloride Tablets, USP, 25 mg, 100-count bottle, Rx only, Manufactured By: Zydus Lifesciences Ltd., Baddi, India; Manufactured for: Northstar Rx LLC Memphis, TN 38141.  NDC: 16714-048-01", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit", "recall_initiation_date": "20250903", "center_classification_date": "20250910", "report_date": "20250917", "code_info": "Lot #: Z305062, exp 31-08-25; Z306324, Exp Date 30-11-25; Z401151, Z401152, Exp Date 28-02-26"}, {"status": "Terminated", "city": "Albuquerque", "state": "NM", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86123", "recalling_firm": "Calvin Scott & Company, Inc.", "address_1": "209 Eubank Blvd Ne", "address_2": "N/A", "postal_code": "87123-2745", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1522-2020", "product_description": "Phendimetrazine Yellow Tabs 35mg, packaged in a) 10-count bags (NDC 69543-0410-11) and b) 28-count bags (NDC 69543-0410-11), and c) 56-count bags (NDC 69543-0410-11)  Rx only, Distributed by: Calvin Scott & Co., Inc. Albuquerque, NM 87123,  Manufactured by Virtus Pharm, LLC.", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.", "recall_initiation_date": "20200727", "center_classification_date": "20200820", "termination_date": "20240411", "report_date": "20200826", "code_info": "a) Lot #: 19236, Exp. Date 10/20  b) Lot #: 19170; 19236, Exp. Date: 09/20; 19303, Exp. Date: 11/20; 19347, Exp. Date: 12/20;  19353, Exp. Date: 01/21:  20032,  20047, Exp. Date: 2/21.  c) Lot #: 19236, Exp. Date 10/20"}, {"status": "Terminated", "city": "Little Rock", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73899", "recalling_firm": "Baptist Health Medical Towers Pharmacy and Infusion Services", "address_1": "9601 Baptist Health Dr Ste 109", "address_2": "N/A", "postal_code": "72205-6323", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Arkansas", "recall_number": "D-0939-2016", "product_description": "TPN 2, (amino acid 20%) 2000 ml bag (140), FOR IV USE ONLY, Baptist Health Medical Towers Pharmacy & Infusion, Little Rock Arkansas", "product_quantity": "86 bags", "reason_for_recall": "Lack of Sterility Assurance", "recall_initiation_date": "20160418", "center_classification_date": "20160529", "termination_date": "20161223", "report_date": "20160608", "code_info": "All product remaining within expiry"}, {"status": "Terminated", "city": "Lincoln", "state": "NE", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M012"], "brand_name": ["THERAFLU"], "generic_name": ["ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL"], "manufacturer_name": ["Haleon US Holdings LLC"], "product_ndc": ["0067-6426"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["ACETAMINOPHEN", "DEXTROMETHORPHAN HYDROBROMIDE", "PHENYLEPHRINE HYDROCHLORIDE"], "rxcui": ["1189316"], "spl_id": ["100acde5-899f-0bed-e063-6294a90aa1a9"], "spl_set_id": ["a4c56ca0-7785-404b-996d-137cc135f270"], "package_ndc": ["0067-6426-01", "0067-6426-06"], "is_original_packager": [true], "unii": ["362O9ITL9D", "9D2RTI9KYH", "04JA59TNSJ"], "upc": ["300676426068", "300676426013"]}, "product_type": "Drugs", "event_id": "65490", "recalling_firm": "Novartis Consumer Health", "address_1": "10401 Hwy 6", "address_2": "", "postal_code": "68517-9626", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide, Mexico, Russia, Korea, Panama, China, and Canada.", "recall_number": "D-752-2014", "product_description": "Theraflu Multi-Symptom Severe Cold (acetaminophen 500 mg, dextromethorphan hydrobromide 20 mg, phenylephrine hydrochloride 10 mg) powder packets, Green Tea & Honey Lemon flavors, packaged in a) 6-count packets per carton (NDC 0067-6426-06, UPC 3 0067-6426-06 8) and b) 1-count packet per card (NDC 0067-6426-01, UPC 3 0067-6426-01 3), Distributed by: Novartis Consumer Health, Inc., Parsippany, NJ  07054-0622.", "product_quantity": "1,202,960 cartons and cards", "reason_for_recall": "Presence of Foreign Substance: The products are being recalled because they may contain foreign substances.", "recall_initiation_date": "20130618", "center_classification_date": "20140117", "termination_date": "20141104", "report_date": "20140129", "code_info": "Lot #: a) 10116016, Exp 6/30/2013; 10118931, Exp 7/31/2013; 10121950, Exp 8/31/2013; 10122314, 10122316, 10124226, Exp 9/30/2013; 10124377, 10124379, 10125916, 10128112, 10128114, Exp 10/31/2013; b) 25872801, Exp 7/31/2013", "more_code_info": ""}, {"country": "United States", "city": "Allen", "address_1": "404 Bastrop Dr", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: These products found to contain undeclared tadalafil. Tadalafil is an FDA-approved drug for the treatment of male Erectile Dysfunction (ED), making these products unapproved new drugs.", "address_2": "", "product_quantity": "8,000 blister packs", "code_info": "All lots", "center_classification_date": "20130516", "distribution_pattern": "Nationwide in the United States, U.S. Virgin Islands, Puerto Rico and to the following locations:      United Kingdom, United Arab Emirates, Turkey, Trinidad & Tobago, Thailand, Taiwan, Sweden, St. Maarten, Spain, South Africa, Singapore, Saudi Arabia, Russia,  Romania, Qatar, Portugal, Poland, Philippines, Papua New Guinea, Pakistan, Oman, Norway, Nigeria, New Zealand, Netherlands Antilles, Netherlands, Mozambique, Montenegro, Mauritius, Malta, Maldives, Malaysia, Latvia, Kuwait, South Korea, Jordan, Japan, Jamaica, Italy, Ireland, Iraq, India, Hong Kong, Guatemala, Greece, Germany, France, England, Denmark, Cyprus, Curacao, Congo, Cayman Islands, Canada, Australia, Belize, and Turks and Caicos Islands.", "state": "TX", "product_description": "a) Firminite 805 mg is packaged in 2 count, 4 count, and 10 count capsules blister packs in a box, WWW.FIRMINITE.COM, b) Libidron 410 mg  is packaged in 2 count, 4 count, and 10 count capsules blister packs in a box, WWW.LIBIDRON.COM , c)Extra Strength Instant Hot Rod 496 mg is packaged in 4 count and 10 count capsule blister packs in a box, www.HotRodExtraStrength.com", "report_date": "20130522", "classification": "Class I", "openfda": {}, "recalling_firm": "InSo-Independent Contractor for West Coast Nutritionals,LTD", "recall_number": "D-326-2013", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "61900", "termination_date": "20150827", "more_code_info": "", "recall_initiation_date": "20120518", "postal_code": "75013-4763", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Cincinnati", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M019"], "brand_name": ["SECRET ANTIPERSPIRANT"], "generic_name": ["ALUMINUM CHLOROHYDRATE"], "manufacturer_name": ["The Procter & Gamble Manufacturing Company"], "product_ndc": ["37000-134"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["ALUMINUM CHLOROHYDRATE"], "spl_id": ["28f210ab-96a1-6ed4-e063-6294a90ada78"], "spl_set_id": ["9f9720c0-a2d7-449c-b97c-19b980322b05"], "package_ndc": ["37000-134-11", "37000-134-17", "37000-134-01"], "is_original_packager": [true], "unii": ["HPN8MZW13M"], "upc": ["037000711094", "037000711087", "037000586906"]}, "product_type": "Drugs", "event_id": "89106", "recalling_firm": "The Procter & Gamble Company", "address_1": "1 Procter And Gamble Plz", "address_2": "N/A", "postal_code": "45202-3315", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA and Puerto Rico, Canada, Guam, Northern Mariana Islands, American Samoa, Bhutan, Timor-Leste, Maldives, Fiji, US Virgin Islands, Trinidad, Peru, Saint Marteen, Bahamas, Costa Rica, Guatemala, Honduras, Panama, Belize, Santa Lucia, Aruba, Dominican Republic, Guyana", "recall_number": "D-0253-2024", "product_description": "Secret, powder fresh, (Aluminum chlorohydrate 24%), Anti-Perspirant/Deodorant, Topical spray can Net Wt., (a) 4OZ (113g), NDC 37000-134-11, UPC 0 37000 71109 4, (b) 6OZ (170g),  NDC 37000-134-17, UPC 0 37000 71108 7; (c) twin pack-2 Topical spray cans, each can Net Wt. 6OZ (170g),  NDC: 37000-134-01, UPC 0 37000 58690 6; Dist. by: Procter & Gamble, Cincinnati, OH 45202,", "product_quantity": "unknown", "reason_for_recall": "CGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzene", "recall_initiation_date": "20211123", "center_classification_date": "20240117", "termination_date": "20241001", "report_date": "20240124", "code_info": "All lots with expiry through September 2023"}, {"status": "Terminated", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72746", "recalling_firm": "Sentara Enterprises", "address_1": "535 Independence Pkwy Ste 300", "address_2": "N/A", "postal_code": "23320-5176", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "U.S. Including: VA, NC", "recall_number": "D-0632-2016", "product_description": "PENICILLIN in D5W, Packaged as a)36MU in 360ML Homepumps and b) 51MU in 510ML Homepumps, Rx Only. SENTARA HOME HEALTH SENTARA RX, 535 Independence Pkwy ste.300, Chesapeake, VA 23320-5176.", "product_quantity": "a)1 Bag, b) 4 Bags", "reason_for_recall": "Lack of Assurance of Sterility: Product sterility cannot be guaranteed.", "recall_initiation_date": "20150918", "center_classification_date": "20160128", "termination_date": "20160629", "report_date": "20160203", "code_info": "All Lots compounded between 11-Sep-15 and 17-Sep-15. Expiries: a) 27-Sep-15, b) 28-Sep-15, 30-Sep-15"}, {"status": "Completed", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91466", "recalling_firm": "Sentara Infusion Services", "address_1": "535 Independence Pkwy Ste 300", "address_2": "N/A", "postal_code": "23320-5176", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Dispensed to Patients Nationwide.", "recall_number": "D-0317-2023", "product_description": "TOBRAMYCIN 660MG IN NS 66ML, antibiotic, Rx Only, use with homepump, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320,", "product_quantity": "2 bags", "reason_for_recall": "Lack of sterility assurance", "recall_initiation_date": "20221227", "center_classification_date": "20230215", "report_date": "20230222", "code_info": "Beyond Use Date, ecember 24, 2022"}, {"status": "Terminated", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84527", "recalling_firm": "MPRX, Inc. dba Medical Park Pharmacy", "address_1": "8230 Elmbrook Dr Ste 600b", "address_2": "N/A", "postal_code": "75247-4144", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "TX", "recall_number": "D-0820-2020", "product_description": "Testosterone Topical Cream 4%", "product_quantity": "3 bottles", "reason_for_recall": "Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.", "recall_initiation_date": "20191218", "center_classification_date": "20200129", "termination_date": "20221213", "report_date": "20200205", "code_info": "Lot: 61463:42 Use by: 02/27/2020"}, {"status": "Ongoing", "city": "Arlington Heights", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M017"], "brand_name": ["CHINA-GEL"], "generic_name": ["MENTHOL AND CAMOHOR (SYNTHETIC)"], "manufacturer_name": ["China-Gel, LLC"], "product_ndc": ["76305-301"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["CAMPHOR (SYNTHETIC)", "MENTHOL"], "rxcui": ["1312283", "1722364"], "spl_id": ["42c8b69f-5f4d-a88b-e063-6294a90a6eae"], "spl_set_id": ["254abae9-ef1b-5a90-e054-00144ff88e88"], "package_ndc": ["76305-301-02", "76305-301-03", "76305-301-04", "76305-301-05", "76305-301-06", "76305-301-07", "76305-301-13"], "is_original_packager": [true], "upc": ["0687806200164", "687806200041", "687806200065", "687806200089", "687806200164", "687806201284"], "unii": ["5TJD82A1ET", "L7T10EIP3A"]}, "product_type": "Drugs", "event_id": "87496", "recalling_firm": "China Gel Inc", "address_1": "501 W Golf Rd", "address_2": "N/A", "postal_code": "60005-3904", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA as well as Australia, Canada, France, Germany, Ireland, Norway, Turks & Caicos, Republic of Maldives, Russia, Singapore, Switzerland, United Kingdom", "recall_number": "D-0789-2021", "product_description": "CHINA-GEL WHITE (Camphor 3.00%, Menthol 5.00%), A TOPICAL PAIN RELIEVER, packaged in a) 2 oz(56.8g) Tube, 76305-301-13  ; b) 4 oz (113.5 g) jar, UPC 6 87806 20004 1, NDC 76305-301-02 ; c) 6 OZ (170 g) tube, UPC 6 87806 20006 5, NDC 76305-301-03; d) 8 oz (226.8 g) Jar, UPC 6 87806 20008 9, NDC  76305-301-04; e) 16 oz ( 453.6 g) Bottle w/ Pump, UPC 6 87806 20016 4, NDC 76305-301-05; f) 120 oz (3.78L) gallon, UPC 6 87806 20128 4, NDC 76305-301-06: Distributed by: CHINA-GEL LLC, Arlington Heights, IL 60005,", "product_quantity": "40,289 each", "reason_for_recall": "CGMP deviations: Product being recalled as it was made in the same facility where contamination with B. cepacia was found in other products.", "recall_initiation_date": "20210310", "center_classification_date": "20210902", "report_date": "20210908", "code_info": "Lot #: a)B100JS, Exp 04/2021; B183GQ, EXP 07-2021; B255KZ, EXP 09-2021; C030HS, EXP 02-2022; C100AH, EXP 04-2022; C247JF, EXP 09-2022;  b)B100JS, Exp 04/2021; B183GQ, EXP 07-2021; B255KZ, EXP 09-2021; C030HS, EXP 02-2022; C100AH, EXP 04-2022; C247JF, EXP 09-2022;  c)B100JS, Exp 04/2021; B183GQ, EXP 07-2021; B255KZ, EXP 09-2021; C030HS, EXP 02-2022; C100AH, EXP 04-2022; C247JF, EXP 09-2022;  d)B100JS, Exp 04/2021; B183GQ, EXP 07-2021; B255KZ, EXP 09-2021; C030HS, EXP 02-2022; C100AH, EXP 04-2022; C247JF, EXP 09-2022;  e)B100JS, Exp 04/2021; B183GQ, EXP 07-2021; B255KZ, EXP 09-2021; C030HS, EXP 02-2022; C100AH, EXP 04-2022; C247JF, EXP 09-2022;  f)B100JS, Exp 04/2021; B183GQ, EXP 09-2021; B255KZ, EXP 09-2021; C030HS, EXP 04-2022; C100AH, EXP 06-2022; C247JF, EXP 10-2022;"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0468-2021", "product_description": "BENICAR 40MG 30; NDC/UPC 65597010430; RX; TABLETS", "product_quantity": "75 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "1703296"}, {"status": "Terminated", "city": "Plainsboro", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82196", "recalling_firm": "Macleods Pharma Usa Inc", "address_1": "666 Plainsboro Rd Bldg 200 Ste 230", "address_2": "N/A", "postal_code": "08536-0009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1003-2019", "product_description": "Telmisartan and Hyrdochlorothiazide Tablets  40mg/12.5 mg, 30-count bottles,  Rx Only, Manufactured for:Macleods Pharma USA, Inc. Plainsboro, NJ 08536, Manufactured for: Macleods Pharmaceuticals Ltd. Baddi, Himchal Pradesh INDIA, NDC 33342-128-07", "product_quantity": "93227 bottles", "reason_for_recall": "Failed Content Uniformity Specifications: The product is out of specification for blend uniformity.", "recall_initiation_date": "20190225", "center_classification_date": "20190314", "termination_date": "20210712", "report_date": "20190320", "code_info": "Lot #: BTL703A, Exp. Feb-19;  BTL705A, Exp Apr-19; BTL706A, BTL707A, BTL708A,  Exp May-19; BTL709A, Exp Nov-19; BTL710A, BTL711A, BTL801A, Exp. Dec-19;  BTL802A, BTL803A,  Exp.Feb-20;  BTL804A, BTL805A, Exp. Apr-20; BTL807A, BTL807B,  Exp May- 20; BTL809A, BTL810A, Exp Jul-20;  BTL811A, Exp Sep-20; BTL812A, BTL813A Exp Oct-20"}, {"status": "Terminated", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078314"], "brand_name": ["NAPROXEN SODIUM"], "generic_name": ["NAPROXEN SODIUM"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-178", "68462-188", "68462-189", "68462-190", "68462-179"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["NAPROXEN SODIUM"], "rxcui": ["198012", "198013", "198014", "849398", "849431"], "spl_id": ["b7cce793-fe49-4fe0-8848-fc89f7ea3832"], "spl_set_id": ["6c5bb008-e66f-4ef0-bf84-aca7eb5983e9"], "package_ndc": ["68462-188-01", "68462-188-05", "68462-189-01", "68462-189-05", "68462-190-30", "68462-190-50", "68462-190-01", "68462-190-05", "68462-178-01", "68462-178-05", "68462-179-01", "68462-179-05"], "is_original_packager": [true], "upc": ["0368462190012", "0368462179017", "0368462178010", "0368462189016", "0368462188019"], "nui": ["N0000000160", "M0001335", "N0000175722"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "unii": ["9TN87S3A3C", "57Y76R9ATQ"]}, "product_type": "Drugs", "event_id": "63264", "recalling_firm": "Glenmark Generics Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1701-2012", "product_description": "NAPROXEN TABLETS USP, 500 mg, 100-count Tablets per bottle, Rx only, Manufactured by: Glenmark Generics Ltd., Colvale-Bardez, Goa 403513, India; Manufactured for: Glenmark Generics Inc., USA, Mahwah, NJ 07430; NDC 68462-190-01.", "product_quantity": "unknown", "reason_for_recall": "Labeling: Label Mix-Up: Bottles labeled as Naproxen Tablets USP, 500 mg, 100-count may contain 90-count Pravastatin Sodium Tablets, 40 mg.", "recall_initiation_date": "20120706", "center_classification_date": "20120927", "termination_date": "20150813", "report_date": "20121003", "code_info": "Lot #: 02112930, 02112934, 02112941, Exp 09/14; 2112985, 02112986, 02113334, Exp 10/14; 02113360, 02113372, 02113420, 02113606, 02113663, 02113664, Exp 11/14.", "more_code_info": ""}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076477"], "brand_name": ["ATORVASTATIN CALCIUM"], "generic_name": ["ATORVASTATIN CALCIUM"], "manufacturer_name": ["Sun Pharmaceutical Industries Inc."], "product_ndc": ["63304-827", "63304-828", "63304-829", "63304-830"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATORVASTATIN CALCIUM TRIHYDRATE"], "rxcui": ["259255", "617310", "617311", "617312"], "spl_id": ["24508d3d-eec0-4c5c-bfaa-d6e01a03fe80"], "spl_set_id": ["595ab888-6b55-4642-a32f-e8521821ed81"], "package_ndc": ["63304-827-90", "63304-827-05", "63304-828-90", "63304-828-05", "63304-829-90", "63304-829-05", "63304-830-90", "63304-830-05"], "is_original_packager": [true], "unii": ["48A5M73Z4Q"]}, "product_type": "Drugs", "event_id": "63759", "recalling_firm": "Ranbaxy Inc.", "address_1": "600 College Rd E Ste 2100", "address_2": "N/A", "postal_code": "08540-6636", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and PR", "recall_number": "D-071-2013", "product_description": "Atorvastatin Calcium Tablets, 20 mg, 90 tablets per bottle, Rx only, Manufactured for: Ranbaxy Pharmaceuticals Inc., Jacksonville, FL 32257, USA, by: Ranbaxy Laboratories Ltd., New Delhi - 110019, India, NDC #: 63304-828-90", "product_quantity": "203,198 Bottles", "reason_for_recall": "Presence of Particulate Matter: Certain batches of Atorvastatin tablets 10 mg, 20 mg and 40 mg may contain small glass particulates.", "recall_initiation_date": "20121109", "center_classification_date": "20121129", "termination_date": "20140428", "report_date": "20121205", "code_info": "Lot #s: 2436731, 2437381, 2437940, 2437942, 2437945, 2437947, 2437952, 2437953, 2437960, 2440676, 2440677, 2440680, 2440681, Exp 08/31/2014."}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92253", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0754-2023", "product_description": "HyperLyte CR  Injection, 500 mL bag, Rx only, Central Admixture Pharmacy Services, 6580 Snowdrift Road, Allentown, PA  18106, NDC 71285-8094-1, code 7128580941.", "product_quantity": "554 bags", "reason_for_recall": "Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.", "recall_initiation_date": "20230428", "center_classification_date": "20230519", "termination_date": "20250622", "report_date": "20230531", "code_info": "Lot # 37-874236, Exp 06/20/2023; 37-878694, Exp 07/10/2023"}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86022", "recalling_firm": "4e Brands North America, Llc", "address_1": "17806 Ih-10 Ste 300", "address_2": "N/A", "postal_code": "78257", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0028-2021", "product_description": "Modesa instant HAND SANITIZER with moisturizers & vitamin E, (70% ethyl alcohol), 33.8 FL OZ (1 L) bottle, Distributed by Greenbrier International, Inc., 500 Volvo Parkway, Chesapeake, VA 23320, Made in Mexico. UPC 0 32251 49935 7", "product_quantity": "17,359,247 total bottles and pumps", "reason_for_recall": "CGMP Deviations: recalled because it was manufactured in the same facility as the product found to contain methanol which represents poor Current Good Manufacturing Practices.", "recall_initiation_date": "20200711", "center_classification_date": "20201007", "termination_date": "20240226", "report_date": "20201007", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-245-2014", "product_description": "Mitomycin 0.02%,2.5ml Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "4 units", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"country": "United States", "city": "Henderson", "address_1": "1850 Whitney Mesa Dr", "reason_for_recall": "Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.", "address_2": "Suite 180", "product_quantity": "996 vials", "code_info": "Lot #: a) Hyaluronidaise 150u/mL: 20130205-G, Exp 5/5/2013; b) Hyaluronidase 150u/mL 1 mL PF: 20130321-A, Exp 6/21/2013; c) Hyaluronidase 150u/mL PF 1ml SDV:  20130313-E, Exp 6/13/2013.  .", "center_classification_date": "20130516", "distribution_pattern": "Nationwide", "state": "NV", "product_description": "Hyaluronidase Injection, all strengths and all presentations including a) Hyaluronidase 150u/mL, b) Hyaluronidase 150u/ml 1 mL PF, c) Hyaluronidase 150u/mL PF 1ml SDV, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV  89014.", "report_date": "20130522", "classification": "Class II", "openfda": {}, "recalling_firm": "FVS Holdings, Inc. dba. Green Valley Drugs", "recall_number": "D-371-2013", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "64879", "termination_date": "20140321", "more_code_info": "", "recall_initiation_date": "20130410", "postal_code": "89014-2091", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212317"], "brand_name": ["DILTIAZEM HYDROCHLORIDE"], "generic_name": ["DILTIAZEM HYDROCHLORIDE"], "manufacturer_name": ["Northstar Rx LLC"], "product_ndc": ["16714-553", "16714-554", "16714-555"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DILTIAZEM HYDROCHLORIDE"], "rxcui": ["830865", "830869", "830872"], "spl_id": ["a11626b3-d7a9-43b0-85d4-38a582acd661"], "spl_set_id": ["e2511ffe-5821-4f64-a469-f8ef9618b1b5"], "package_ndc": ["16714-553-01", "16714-554-01", "16714-555-01"], "is_original_packager": [true], "upc": ["0316714554013", "0316714553016", "0316714555010"], "unii": ["OLH94387TE"]}, "product_type": "Drugs", "event_id": "95660", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0098-2025", "product_description": "Diltiazem Hydrochloride Extended-Release Capsules, USP 120mg, Twice-a-Day Dosage, Rx Only, 100 Capsules per bottle, Mfd for: Northstar Rx LLC, Memphis, TN, Mfd by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh India, NDC 16714-555-01.", "product_quantity": "7296 bottles", "reason_for_recall": "cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit.", "recall_initiation_date": "20241101", "center_classification_date": "20241203", "report_date": "20241211", "code_info": "Lot #:17222547, Exp. Date, 11/30/2024; 17230598, Exp. Date 02/28/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83669", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0275-2020", "product_description": "S-MIC 25/50/50MG/ML B12A1MG/ML MDV INJ SOLN; Rx Only, a) 10ML b) 30ML glass vial. Red Mountain Compounding RX.", "product_quantity": "108x 10 and 30 ml glass vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190812", "center_classification_date": "20191105", "termination_date": "20230413", "report_date": "20191113", "code_info": "Lot #: a) S03272019DT@04, Exp 09/27/2019,  b) S01302019DT@08, Exp 08/30/2019, S02192019DH@10, Exp 08/19/2019, S03072019DH@01, Exp 09/07/2019, S03042019DH@02, Exp 09/07/2019, S03272019DT@04, Exp 09/27/2019, S04172019DT@03, Exp 10/17/2019, S04302019DT@11, Exp 10/30/2019, S05162019DH@20, Exp 11/16/2019,  S05292019DT@03, Exp 11/29/2019, S06252019DH@17, Exp 12/25/2019, S07172019DT@12, Exp 01/17/2020, S07182019DT@08, Exp 01/18/2020,"}, {"country": "United States", "city": "Orlando", "address_1": "6700 Conroy Windermere Rd", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes", "address_2": "Suite 140", "product_quantity": "1", "code_info": "A5414 Exp 12/31/13", "center_classification_date": "20130711", "distribution_pattern": "Nationwide and PR", "state": "FL", "product_description": "Dextrose 50% Solution, compounded by Olympia Pharmacy, Orlando, FL", "report_date": "20130717", "classification": "Class II", "openfda": {}, "recalling_firm": "Lowlite Investments, Inc. D/B/A Olympia Pharmacy", "recall_number": "D-721-2013", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "65360", "recall_initiation_date": "20130529", "postal_code": "32835-3500", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"status": "Terminated", "city": "Corvallis", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82278", "recalling_firm": "Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy", "address_1": "996 Nw Circle Blvd Ste 105", "address_2": "N/A", "postal_code": "97330-1485", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Dispensed in Oregon", "recall_number": "D-1098-2019", "product_description": "PGE1-LIDOCAINE 40 MCG-1% /ML* INJECTABLE, (a) 10 ml (b) 9ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .", "product_quantity": "25 prescriptions 10, 9, ml injectable", "reason_for_recall": "Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.", "recall_initiation_date": "20190221", "center_classification_date": "20190409", "termination_date": "20200723", "report_date": "20190417", "code_info": "Lot:(a) 26092018@22, 26092018@22, 09102018@47, 15102018@33, 15102018@33, 09102018@47, 15102018@33, 09102018@47, 29112018@4,  10122018@14, 29112018@4, 29112018@4, 19122018@20, 21122018@29, 21122018@29, 27122018@20, (b) 16012019@59, 18012019@17, 21012019@49, 21012019@49, 22012019@24, 22012019@24, distributed between 09-01-2018 to 02-20-2019."}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0884-2019", "product_description": "Dr. King's SafeCare Rx Allergies: Fruits & Vegetables, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955250128, NDC 57955-2501-2", "product_quantity": "61 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 112117E Exp. 11/19; 091216B Exp. 09/19"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: VERAPAMIL HCL, Tablet, 40 mg may have potentially been mislabeled as one of the following drugs:  ATORVASTATIN CALCIUM, Tablet, 10 mg, NDC 00378201577, Pedigree: W003095, EXP: 6/12/2014;  TACROLIMUS, Capsule, 1 mg, NDC 00781210301, Pedigree: W003352, EXP: 3/31/2014.", "address_2": "", "product_quantity": "196 Tablets", "code_info": "VERAPAMIL HCL, Tablet, 40 mg has the following codes:   Pedigree: W003170, EXP: 6/13/2014;  Pedigree: W003353, EXP: 6/18/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "VERAPAMIL HCL, Tablet, 40 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00591040401.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-962-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}]